Lexeo Therapeutics, Inc. Common Stock (LXEO) — Analyst estimates
Consensus analyst estimates for Lexeo Therapeutics, Inc. Common Stock — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 0 | -0.32 | 4 |
| 2027 | 4.67M | -0.3 | 2 |
| 2028 | 77.01M | -0.75 | 5 |
| 2029 | 266.45M | 0.59 | 1 |
| 2030 | 526.95M | 2.71 | 1 |
Consensus analyst estimates by fiscal year.